Skip Nav Destination
Issues
1 August 2003
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Issue Sections
ARTICLE
Expression and Targeting of Human Fibroblast Activation Protein in a Human Skin/Severe Combined Immunodeficient Mouse Breast Cancer Xenograft Model
Kiki Tahtis; Fook-Thean Lee; Jennifer M. Wheatley; Pilar Garin-Chesa; John E. Park; Fiona E. Smyth; Yuichi Obata; Elisabeth Stockert; Cathrine M. Hall; Lloyd J. Old; Wolfgang J. Rettig; Andrew M. Scott
Combination Treatment with 1α,25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Directly Inhibits Human Telomerase Reverse Transcriptase Transcription in Prostate Cancer Cells
Naoya Ikeda; Hiroji Uemura; Hitoshi Ishiguro; Mayumi Hori; Masahiko Hosaka; Satoru Kyo; Ken-ichi Miyamoto; Eiji Takeda; Yoshinobu Kubota
Gene-directed Enzyme Prodrug Therapy for Osteosarcoma: Sensitization to CPT-11 in Vitro and in Vivo by Adenoviral Delivery of a Gene Encoding Secreted Carboxylesterase-21
Dinja Oosterhoff; M. Adhiambo Witlox; Victor W. van Beusechem; Hidde J. Haisma; Gerard R. Schaap; Johannes Bras; Frank A. Kruyt; Bonnie Molenaar; Epie Boven; Paul I. J. M. Wuisman; Herbert M. Pinedo; Winald R. Gerritsen
Minireview
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.